Nutritional Status of High Risk Pregnant Women and their Relationship with clinical profile and quality of life.
pregnancy, pandemic, nutritional
Worldwide, there has been an increase in the prevalence of overweight and obesity. According to 2019 IBGE data, 1.6% of the adult population had weight loss, 60.3% were overweight, with a prevalence of obesity in 25.9%. Several studies evaluate the effects of maternal nutritional status on gestational complications and unfavorable outcomes for maternal and newborns, but few studies address this assessment in the context of high-risk pregnancies. In addition to the clinical status, the quality of life of the pregnant woman could be impacted during the gestational period, since it is a time of many changes. Objective: to evaluate the nutritional status of high-risk pregnant women attended at the Professor Alberto Antunes University Hospital and its relationship with the occurrence of gestational complications, outcomes for the newborn and quality of life of pregnant women. Results: the prevalence of underweight in the sample studied was 5.66%, overweight was 73.58%, 33.96% overweight and 39.62% obese. The percentage of pregnant women with insufficient weight gain was 20.75% and excessive gain was 49.06%. There was a higher prevalence of complications related to hypertensive syndrome in obese patients and higher occurrence of infectious complications and prematurity in those with low weight. The weight of the NB at birth showed a difference between the groups, with a mean lower weight in the groups of low weight and eutrophy, while the mean higher weight occurred in the obese group. There were no differences in quality of life scores in relation to nutritional status. Conclusion: The high prevalence of obesity in high-risk pregnant women and the association between maternal nutritional status and the occurrence of conditions that interfere with maternal and newborn perinatal outcomes highlights the importance of measures aimed at improving the nutritional status of women prior to pregnancy and during prenatal follow-up.